A Study of Tasisulam in Treating Participants With Malignant Melanoma

Summary

The primary purpose of this study is to determine the objective response rate (complete and partial response) for participants who receive tasisulam after one prior systemic treatment for unresectable or metastatic melanoma.

Timeline

Start

2006-11

Primary completion

2011-09

Completion

2015-07

Drugs

Indications